Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Polycystic Ovary Syndrome
100%
Insulin Sensitivity
100%
Circulating Lipids
100%
Minimal Responses
100%
Troglitazone
100%
High-density Lipoprotein Cholesterol (HDL-C)
60%
Low-density Lipoprotein Cholesterol (LDL-C)
60%
Placebo
40%
Dyslipidemia
40%
Insulin Action
40%
Lipid Parameters
40%
Insulin Sensitizers
40%
Total Cholesterol
40%
Non-responders
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Treatment Effect
20%
Minimal Impact
20%
High Prevalence
20%
Lipid Levels
20%
Insulin Resistance
20%
Intention-to-treat Analysis
20%
National Cholesterol Education Program
20%
Response to Treatment
20%
Predictive Power
20%
Minimal Treatment
20%
Double-blind Trial
20%
Thiazolidinediones
20%
Circulating Lipoproteins
20%
Glycemic Parameters
20%
Low-density Lipoprotein Triglyceride
20%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Polycystic Disease
100%
Troglitazone
100%
Lipid
100%
Insulin
100%
High Density Lipoprotein Cholesterol
42%
Low Density Lipoprotein Cholesterol
42%
Cholesterol
42%
Placebo
28%
Prevalence
28%
Dyslipidemia
28%
Insulin Sensitizing Agent
28%
Insulin Resistance
14%
Triacylglycerol
14%
Thiazolidinedione
14%
Lipoprotein
14%
Maturity Onset Diabetes of the Young
14%
Immunology and Microbiology
Ovary
100%
Insulin Sensitivity
100%
Insulin
100%
Arm
75%
High-Density Lipoprotein
75%
Low-Density Lipoprotein
75%
Prevalence
50%
Cholesterol Blood Level
50%
Insulin Resistance
25%
Lipid Level
25%
Lipoprotein
25%
Neuroscience
Insulin
100%
Lipid
100%
High Density Lipoprotein Cholesterol
42%
Low Density Lipoprotein Cholesterol
42%
Cholesterol
42%
Placebo
28%
Dyslipidemia
28%
Triacylglycerol
14%
Thiazolidinedione
14%